RxDoctor Payments Data

Poghni Peri-Okonny, MD

Interventional Cardiology · Winchester, VANPI 1114293206

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (46.9%), food and beverage and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 74.0% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $1,505, 4.7 times the $322 reported in 2022. That places this record below the midpoint for interventional cardiology clinicians in VA, where the typical reported total is $4,743.

$2,005in general payments, 2019–2025

Across 29 payments — averaging $69.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Bard Peripheral Vascular, Inc.$124
  • Boston Scientific$71
  • Inari Medical, Inc.$62
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$56
  • Boehringer Ingelheim$55
  • plus $154 from 6 others

What the payments were for

  • Travel & lodging$94147%
  • Food & beverage$84442%
  • Education$22011%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,005 in reported general payments places this provider in the 25th percentile of 176 interventional cardiology providers in Virginia.

See all interventional cardiology providers in Virginia →

Medicare billing

Part B allowed, 2024
$74,516
Medicare patients
428
Services billed
864

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$19,313
ClopidogrelClopidogrel Bisulfate46$542
Metoprolol Succinate14$107
Amlodipine Besylate11$51

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Winchester

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →